These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15949070)

  • 21. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients.
    Glass TR; De Geest S; Hirschel B; Battegay M; Furrer H; Covassini M; Vernazza PL; Bernasconi E; Rickenboch M; Weber R; Bucher HC;
    Antivir Ther; 2008; 13(1):77-85. PubMed ID: 18389901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
    Moore DM; Hogg RS; Yip B; Wood E; Harris M; Montaner JS
    HIV Med; 2006 Jul; 7(5):311-6. PubMed ID: 16945076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicians' communication with patients about adherence to HIV medication in San Francisco and Copenhagen: a qualitative study using Grounded Theory.
    Barfod TS; Hecht FM; Rubow C; Gerstoft J
    BMC Health Serv Res; 2006 Dec; 6():154. PubMed ID: 17144910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes.
    Liu H; Miller LG; Golin CE; Hays RD; Wu T; Wenger NS; Kaplan AH
    Stat Med; 2007 Feb; 26(5):991-1007. PubMed ID: 16755546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
    Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
    Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Factors associated with adherence in HIV patients].
    Arrondo Velasco A; Sainz Suberviola ML; Andrés Esteban EM; Iruin Sanz AI; Napal Lecumberri V
    Farm Hosp; 2009; 33(1):4-11. PubMed ID: 19401092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to antiretroviral therapy: appropriate use of self-reporting in clinical practice.
    Pratt RJ; Robinson N; Loveday HP; Pellowe CM; Franks PJ; Hankins M; Loveday C
    HIV Clin Trials; 2001; 2(2):146-59. PubMed ID: 11590523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of pharmacy-implemented medication reconciliation directed at antiretroviral therapy in hospitalized HIV/AIDS patients.
    Corrigan MA; Atkinson KM; Sha BE; Crank CW
    Ann Pharmacother; 2010 Jan; 44(1):222-3. PubMed ID: 20040697
    [No Abstract]   [Full Text] [Related]  

  • 31. PI therapy evaluated for three months.
    AIDS Alert; 1999 Jan; 14(1):11-2. PubMed ID: 11366088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The contribution of hospital pharmacy departments to HIV-infected patient care].
    Knobel Freud H
    Farm Hosp; 2004; 28(6 Suppl 1):1-5. PubMed ID: 15649110
    [No Abstract]   [Full Text] [Related]  

  • 33. Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications.
    Marhefka SL; Koenig LJ; Allison S; Bachanas P; Bulterys M; Bettica L; Tepper VJ; Abrams EJ
    AIDS Patient Care STDS; 2008 Aug; 22(8):637-47. PubMed ID: 18627275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to prescribed HIV-1 protease inhibitors in the home setting.
    Ungvarski P
    J Assoc Nurses AIDS Care; 1997; 8 Suppl():37-45. PubMed ID: 9356961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancies between medical and pharmacy records for patients on anti-HIV drugs.
    de Maat MM; Frankfort SV; Mathôt RA; Mulder JW; Meenhorst PL; van Gorp EC; Koks CH; Hoetelmans RM; de Boer A; Beijnen JH
    Ann Pharmacother; 2002 Mar; 36(3):410-5. PubMed ID: 11898804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of HIV medication adherence in relation to person and treatment characteristics using hierarchical linear modeling.
    Halkitis P; Palamar J; Mukherjee P
    AIDS Patient Care STDS; 2008 Apr; 22(4):323-35. PubMed ID: 18290734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of pharmacy refill data as a measure of antiretroviral adherence.
    Grossberg R; Gross R
    Curr HIV/AIDS Rep; 2007 Dec; 4(4):187-91. PubMed ID: 18366950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Determinants of antiretroviral treatment adherence in Brasília, Federal District: a case-control study].
    de Carvalho CV; Merchán-Hamann E; Matsushita R
    Rev Soc Bras Med Trop; 2007; 40(5):555-65. PubMed ID: 17992413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Response to comment on "Medication reconciliation by a pharmacist in patients with human immunodeficiency virus on antiretroviral therapy: the needed balance of availability and expertise".
    Foisy MM; Li EH
    Ann Pharmacother; 2014 Nov; 48(11):1535-6. PubMed ID: 25301829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmaceutical care of HIV-infected patients: the role of HIV-SEFH group].
    Ortega Valín L
    Farm Hosp; 2004; 28(6 Suppl 1):80-4. PubMed ID: 15649119
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.